{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:19:44Z","timestamp":1791141584523,"version":"4.1.0"},"reference-count":69,"publisher":"American Geophysical Union (AGU)","issue":"11","license":[{"start":{"date-parts":[[1998,11,1]],"date-time":"1998-11-01T00:00:00Z","timestamp":909878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[1998,11]]},"DOI":"10.1021\/js9800836","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T09:40:54Z","timestamp":1030268454000},"page":"1308-1315","source":"Crossref","is-referenced-by-count":61,"title":["Drug Delivery of Antisense Molecules to the Brain for Treatment of Alzheimer\u2019s Disease and Cerebral AIDS"],"prefix":"10.1029","volume":"87","author":[{"given":"Ruben J.","family":"Boado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhisa","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Pardridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"13","reference":[{"key":"10.1021\/js9800836_bb0010","first-page":"47","article-title":"Antisense approaches to cancer gene therapy","volume":"2","author":"Mercola","year":"1995","journal-title":"Cancer Gene Ther."},{"key":"10.1021\/js9800836_bb0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1357-4310(96)10053-8","article-title":"Antisense technology and prospects for therapy of viral infections and cancer","volume":"3","author":"Wagner","year":"1997","journal-title":"Mol. Med. Today"},{"key":"10.1021\/js9800836_bb0020","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0163-7258(97)00005-3","article-title":"Oligonucleotides as modulators of cancer gene expression","volume":"74","author":"Curcio","year":"1997","journal-title":"Pharmacol. Ther."},{"key":"10.1021\/js9800836_bb0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0169-409X(95)00006-S","article-title":"Antisense drug delivery through the blood-brain barrier","volume":"15","author":"Boado","year":"1995","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1021\/js9800836_bb0030","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1440-1681.1994.tb02655.x","article-title":"Antisense oligo-nucleotides: a new tool in neuroscience","volume":"21","author":"Pilowsky","year":"1994","journal-title":"Clin. Exp. Pharma-col. Physiol."},{"key":"10.1021\/js9800836_bb0035","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF02359384","article-title":"Application of antisense DNA method for the study of molecular bases of brain function and behavior","volume":"26","author":"Ogawa","year":"1996","journal-title":"Behav. Genet."},{"key":"10.1021\/js9800836_bb0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0197-0186(96)00105-2","article-title":"Antisense strategies in neurobiology","volume":"31","author":"Weiss","year":"1997","journal-title":"Neurochem. Int."},{"key":"10.1021\/js9800836_bb0045","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0197-0186(96)00106-4","article-title":"Critical issues in the antisense inhibiton of brain gene expression in vivo: experiences targeting the 5-HT1A receptor","volume":"31","author":"Le Corre","year":"1997","journal-title":"Neurochem. Int."},{"key":"10.1021\/js9800836_bb0050","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0169-409X(95)00003-P","article-title":"Transport of small molecules through the blood-brain barrier: biology and methodology","volume":"15","author":"Pardridge","year":"1995","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1021\/js9800836_bb0055","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1006\/exnr.1997.6567","article-title":"Down-regulation of mGluR5 by antisense deoxynucleotides alters pharmacological responses to applications of ACPD in the rat hippocampus","volume":"147","author":"Dorri","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1021\/js9800836_bb0060","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1073\/pnas.90.10.4665","article-title":"Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system","volume":"90","author":"Whitesell","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1021\/js9800836_bb0065","series-title":"Prospects for Antisense Nucleic Acid Therapy of Cancer and AIDS","first-page":"143","article-title":"Antisense oligonucleotides: a possible approach for chemotherapy of AIDS","author":"Agrawal","year":"1991"},{"key":"10.1021\/js9800836_bb0070","first-page":"404","article-title":"Chronic intrathecal infusion of phosphorothioate or phosphodiester antisense oligonucelotides against cytokine responsive gene-2\/IP-10 in experimental allergic encephalomyelitis of Lewis rat","volume":"278","author":"Wojcik","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1021\/js9800836_bb0075","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1021\/bc00029a005","article-title":"Complete inactivation of target mRNA by biotinylated antisense oligodeoxynucleotide-avidin conjugates","volume":"5","author":"Boado","year":"1994","journal-title":"Bioconj. Chem."},{"key":"10.1021\/js9800836_bb0080","first-page":"55","article-title":"Pharmacokinetics and organ clearance of a 3\u2032-biotinylated, internally [32P]-labeled phosphodiester oligodeoxynucleotide coupled to a neutral avidin\/monoclonal antibody conjugate","volume":"23","author":"Kang","year":"1995","journal-title":"Drug Metab. Dispos."},{"key":"10.1021\/js9800836_bb0085","first-page":"496","article-title":"Determination of postglomeru-lar perme-selectivity to neutral dextrans in the dog","volume":"245","author":"Whiteside","year":"1983","journal-title":"Am. J. Physiol."},{"key":"10.1021\/js9800836_bb0090","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1172\/JCI113625","article-title":"Desialation of transferrin by rat liver endothelium","volume":"82","author":"Irie","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1021\/js9800836_bb0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/ard.1993.3.53","article-title":"Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothio-ate and methylphosphonate oligonucleotides","volume":"3","author":"Zhao","year":"1993","journal-title":"Antisense Res. Devel."},{"key":"10.1021\/js9800836_bb0100","first-page":"33","article-title":"Chimeric oligodeoxy-nucleotide analogues: enhanced cell uptake of structures which direct ribonuclease H with high specificity","volume":"8","author":"Giles","year":"1993","journal-title":"Anti-Cancer Drug Design"},{"key":"10.1021\/js9800836_bb0105","doi-asserted-by":"crossref","first-page":"26801","DOI":"10.1016\/S0021-9258(18)47090-1","article-title":"Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding","volume":"269","author":"Brown","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1021\/js9800836_bb0110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1089\/ard.1994.4.173","article-title":"Use of partially phosphorothioated \u2018antisense\u2019 oligodeoxynucleotides for sequence-dependent modulation of hematopoiesis in culture","volume":"4","author":"Ehrlich","year":"1994","journal-title":"Antisense Res. Devel."},{"key":"10.1021\/js9800836_bb0115","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1073\/pnas.94.6.2620","article-title":"Mixed-backbone oligonucleotides as second generation antisense oligonucelotides: in vitro and in vivo studies","volume":"94","author":"Agrawal","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1021\/js9800836_bb0120","first-page":"1297","article-title":"Rapid plasma clearance and metabolism in vivo of a phosphorothio-ate oligodeoxynucleotide with a single, internal phosphodi-ester bond","volume":"23","author":"Boado","year":"1995","journal-title":"Drug Metab. Dispos."},{"key":"10.1021\/js9800836_bb0125","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1021\/bc00018a010","article-title":"Complete protection of antisense oligonucleotides against serum nuclease degradation by an avidin-biotin system","volume":"3","author":"Boado","year":"1992","journal-title":"Bioconj. Chem."},{"key":"10.1021\/js9800836_bb0130","first-page":"609","article-title":"In vitro toxicology and pharmacokinetics of antisense oligonucleotides","volume":"6","author":"Crooke","year":"1991","journal-title":"Anti-Cancer Drug Design"},{"key":"10.1021\/js9800836_bb0135","doi-asserted-by":"crossref","first-page":"11823","DOI":"10.1073\/pnas.89.24.11823","article-title":"In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides","volume":"89","author":"Ratajczak","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1021\/js9800836_bb0140","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jcla.1860090210","article-title":"Review of in vivo pharmaco-kinetics and toxicology of phosphorothioate oligonucleotides","volume":"9","author":"Srinivasan","year":"1995","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1021\/js9800836_bb0145","first-page":"206","article-title":"Pharmacokinetics and blood-brain barrier transport of [3H]-biotinylated phospho-rothioate oliogodeoxynucleotide conjugated to a vector-mediated drug delivery system","volume":"276","author":"Wu","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1021\/js9800836_bb0150","series-title":"Prospects for Antisense Nucleic Acid Therapy of Cancer and AIDS","first-page":"159","article-title":"A new concept in AIDS treatment: an antisense approach and its current status towards clinical application","author":"Matsukura","year":"1991"},{"key":"10.1021\/js9800836_bb0155","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/0006-2952(94)90171-6","article-title":"Stability of peptide nucleic acids in human serum and cellular extracts","volume":"48","author":"Demidov","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1021\/js9800836_bb0160","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/0026-0495(87)90099-0","article-title":"Human blood-brain barrier transferrin receptor","volume":"36","author":"Pardridge","year":"1987","journal-title":"Metabolism"},{"key":"10.1021\/js9800836_bb0165","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/312162a0","article-title":"Transferrin receptor on endothelium of brain capillaries","volume":"312","author":"Jefferies","year":"1984","journal-title":"Nature"},{"key":"10.1021\/js9800836_bb0170","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1073\/pnas.92.12.5592","article-title":"Vector-mediated delivery of a polyamide (\u201cpeptide\u201d) nucleic acid analogue through the blood-brain barrier in vivo","volume":"92","author":"Pardridge","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1021\/js9800836_bb0175","first-page":"768","article-title":"Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared to morphine","volume":"25","author":"Wu","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1021\/js9800836_bb0180","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1056\/NEJM198604103141506","article-title":"Alzheimer's disease","volume":"314","author":"Katzman","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1021\/js9800836_bb0185","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","article-title":"The molecular pathology of Alzheimer's disease","volume":"6","author":"Selkoe","year":"1991","journal-title":"Neuron"},{"key":"10.1021\/js9800836_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-4835(77)80008-0","article-title":"Morphology of blood-brain interfaces","volume":"25","author":"Brightman","year":"1977","journal-title":"Exp. Eye Res."},{"key":"10.1021\/js9800836_bb0195","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/10717549309022762","article-title":"Brain drug delivery and blood-brain barrier transport","volume":"1","author":"Pardridge","year":"1993","journal-title":"Drug Deliv."},{"key":"10.1021\/js9800836_bb0200","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.3299701","article-title":"Localization of amyloid beta protein messenger RNA in brains from patients with Alzheimer's disease","volume":"237","author":"Bahmanyar","year":"1987","journal-title":"Science"},{"key":"10.1021\/js9800836_bb0205","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1002\/j.1460-2075.1987.tb02694.x","article-title":"Neuronal localization of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer's disease","volume":"6","author":"Goedert","year":"1987","journal-title":"EMBO J."},{"key":"10.1021\/js9800836_bb0210","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1126\/science.3810169","article-title":"Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzhaimer's disease","volume":"235","author":"Goldgaber","year":"1987","journal-title":"Science"},{"key":"10.1021\/js9800836_bb0215","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/325733a0","article-title":"The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor","volume":"325","author":"Kang","year":"1987","journal-title":"Nature"},{"key":"10.1021\/js9800836_bb0220","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1073\/pnas.84.12.4190","article-title":"Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides","volume":"84","author":"Robakis","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1021\/js9800836_bb0225","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.2949367","article-title":"Amyloid beta protein gene: cDNA, mRNA distribution, and genetic likage near the Alzheimer locus","volume":"235","author":"Tanzi","year":"1987","journal-title":"Science"},{"key":"10.1021\/js9800836_bb0230","first-page":"163","article-title":"Expression of the amyloid beta-protein precursor gene","volume":"51","author":"Goldgaber","year":"1990","journal-title":"Adv. Neurol."},{"key":"10.1021\/js9800836_bb0235","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1073\/pnas.85.4.1297","article-title":"Differential regulation of amyloid-beta-protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease","volume":"85","author":"Higgins","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1021\/js9800836_bb0240","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1073\/pnas.85.5.1691","article-title":"Distribution of precursor amyloid-beta-protein messenger RNA in human cerebral cortex: relationship to neurofibrillary tangles and neuritic plaques","volume":"85","author":"Lewis","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1021\/js9800836_bb0245","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0896-6273(88)90166-3","article-title":"Expression of the Alzheimer amyloid precursor gene transcripts in the human brain","volume":"1","author":"Neve","year":"1988","journal-title":"Neuron"},{"key":"10.1021\/js9800836_bb0250","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1749-6632.1991.tb00207.x","article-title":"Studies of amyloid beta-protein precursor expression in Alzheimer's disease","volume":"640","author":"Tanzi","year":"1991","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1021\/js9800836_bb0255","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1126\/science.2457949","article-title":"Amyloid protein precursor messenger RNAs: differential expression in Alzheimer's disease","volume":"242","author":"Palmert","year":"1988","journal-title":"Science"},{"key":"10.1021\/js9800836_bb0260","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0197-4580(91)90090-7","article-title":"Quantitative measurement of alternatively spliced amyloid precursor protein mRNA expression in Alzheimer's disease and normal brain by S1 nuclease protection analysis","volume":"12","author":"Jacobsen","year":"1991","journal-title":"Neurobiol. Aging"},{"key":"10.1021\/js9800836_bb0265","doi-asserted-by":"crossref","first-page":"7789","DOI":"10.1073\/pnas.90.16.7789","article-title":"Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity","volume":"90","author":"Takashima","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1021\/js9800836_bb0270","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/BF00712843","article-title":"Interleukin-1 stimulates the beta-amyloid precursor protein promoter","volume":"10","author":"Donnelly","year":"1990","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1021\/js9800836_bb0275","doi-asserted-by":"crossref","first-page":"7606","DOI":"10.1073\/pnas.86.19.7606","article-title":"Inter-leukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells","volume":"86","author":"Goldgaber","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1021\/js9800836_bb0280","doi-asserted-by":"crossref","first-page":"9811","DOI":"10.1073\/pnas.85.24.9811","article-title":"Nerve growth factor increases mRNA levels for the prion protein and the beta-amyloid protein precursor in developing hamster brain","volume":"85","author":"Mobley","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1021\/js9800836_bb0285","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/373523a0","article-title":"Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein","volume":"373","author":"Games","year":"1995","journal-title":"Nature"},{"key":"10.1021\/js9800836_bb0290","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0006-8993(97)00757-9","article-title":"Down-regulation of the amyloid protein precursor of Alzheimer's disease by antisense oligonucleotides reduces neuronal adhesion to specific substrata","volume":"770","author":"Coulson","year":"1997","journal-title":"Brain Res."},{"key":"10.1021\/js9800836_bb0295","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.410190602","article-title":"The AIDS dementia complex: I. Clinical features","volume":"19","author":"Navia","year":"1986","journal-title":"Ann. Neurol."},{"key":"10.1021\/js9800836_bb0300","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ana.410190603","article-title":"The AIDS dementia complex: II","volume":"19","author":"Navia","year":"1986","journal-title":"Neuropathology. Ann. Neurol."},{"key":"10.1021\/js9800836_bb0305","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1212\/WNL.38.1.9","article-title":"Early penetration of the blood-brain barrier by HIV","volume":"38","author":"Resnick","year":"1988","journal-title":"Neurology"},{"key":"10.1021\/js9800836_bb0310","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1128\/CMR.6.4.339","article-title":"Human immunodeficiency virus type 1 infection of the brain","volume":"6","author":"Atwood","year":"1993","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1021\/js9800836_bb0315","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1084\/jem.166.4.1138","article-title":"Modulation of CD4 antigen on macrophages and microglia in rat brain","volume":"166","author":"Perry","year":"1987","journal-title":"J. Exp. Med."},{"key":"10.1021\/js9800836_bb0320","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev.pa.36.040196.002553","article-title":"Structural mechanisms of HIV drug resistance","volume":"36","author":"Erickson","year":"1996","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1021\/js9800836_bb0325","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00003495-199652010-00007","article-title":"Saquinavir. A review of its pharmacology and clinical potential in the management of HIV infection","volume":"52","author":"Noble","year":"1996","journal-title":"Drugs"},{"key":"10.1021\/js9800836_bb0330","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0149-2918(97)80110-5","article-title":"Protease inhibitors: a therapeutic breakthrough for the treatment of patients with human immunodeficiency virus","volume":"19","author":"Lewis","year":"1997","journal-title":"Clin. Ther."},{"key":"10.1021\/js9800836_bb0335","series-title":"Prospects for Antisense Nucleic Acid Therapy of Cancer and AIDS","first-page":"159","article-title":"A new concept in AIDS treatment: an antisense approach and its current status towards clinical application","author":"Matsukura","year":"1991"},{"key":"10.1021\/js9800836_bb0340","series-title":"Prospects for Antisense Nucleic Acid Therapy of Cancer and AIDS","first-page":"143","article-title":"Antisense oligonucleotides: a possible approach for chemotherapy of AIDS","author":"Agrawal","year":"1991"},{"key":"10.1021\/js9800836_bb0345","doi-asserted-by":"crossref","first-page":"7942","DOI":"10.1073\/pnas.91.17.7942","article-title":"Antisense oligodeoxy-nucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells","volume":"91","author":"Lisziewicz","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1021\/js9800836_bb0350","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/infdis\/158.3.630","article-title":"Restricted transport of 3\u2032-azido-3\u2032-deoxythymidine and dideoxynucleosides through the blood-brain barrier","volume":"158","author":"Terasaki","year":"1988","journal-title":"J. Infect. Dis."}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235491550676X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235491550676X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T13:03:23Z","timestamp":1626872603000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235491550676X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,11]]},"references-count":69,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1998,11]]}},"alternative-id":["S002235491550676X"],"URL":"https:\/\/doi.org\/10.1021\/js9800836","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[1998,11]]}}}